Valuation: Alpa Laboratories Limited

Market Cap 1.1B 11.6M 10.33M 9.57M 8.68M 16.3M 16.58M 115M 45.13M 575M 43.53M 42.63M 1.84B P/E 2025
11.2x
P/E 2026 6.51x
Enterprise Value -254M -2.69M -2.39M -2.22M -2.01M -3.77M -3.84M -26.58M -10.44M -133M -10.07M -9.86M -425M EV / Sales 2025
0.94x
EV / Sales 2026 -0.36x
Free-Float
42.71%
Yield 2025 *
-
Yield 2026 -
10-12 Alpa Laboratories Limited Approves Appointment of Radhika Biyani as an Independent Director, Effective September 30, 2026 CI
09-17 Alpa Laboratories Limited Announces Appointment of Diksha Jaswani as Company Secretary Cum Compliance Officer, Effective September 17, 2026 CI
08-13 Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
07-22 Alpa Laboratories Ltd. Announces Cessation of Ms. Jyoti Jain as an Independent Director, Effective July 21, 2026 CI
07-08 Alpa Laboratories Limited Announces Resignation of Yashoda Patidar as Company Secretary and Compliance Officer, Effective July 26, 2026 CI
05-29 Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
04-11 Alpa Laboratories Limited Appoints Ms. Yashoda Patidar as Company Secretary and Compliance Officer, Effective April 11, 2026 CI
02-25 Alpa Laboratories Limited Announces Resignation of Srashti Chopra as Company Secretary and Compliance Officer, Effective March 25, 2026 CI
02-11 Alpa Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
13/08/25 Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
31/07/25 Brookfield India Real Estate Trust announced that it expects to receive INR 10.00000015 billion in funding from a group of investors CI
28/05/25 Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
14/02/25 Alpa Laboratories Limited Announces Change in Designation of Vitthal Kothana from Non- Executive Director to Executive Director CI
1 day-1.97%
1 week-10.75%
Current month-13.93%
1 month-14.09%
3 months-24.28%
6 months-25.54%
Current year-34.07%
1 week 50.61
Extreme 50.61
59
1 month 50.61
Extreme 50.61
62.35
Current year 46.1
Extreme 46.1
80.08
1 year 46.1
Extreme 46.1
93.85
3 years 46.1
Extreme 46.1
144.5
5 years 46.1
Extreme 46.1
144.5
10 years 11
Extreme 11
144.5
Manager TitleAgeSince
Chief Executive Officer - 27/05/2016
Director of Finance/CFO 65 -
Director TitleAgeSince
Chairman 83 -
Director/Board Member 77 31/12/1966
Director/Board Member - 27/05/2016
Change 5-day change 1-year change 3-year change Capi.($)
-1.97%-10.75%-41.99%-29.30% 11.6M
+3.49%+10.04%+58.68%+119.56% 1,144B
+2.19%+4.32%+33.88%+69.52% 625B
+2.26%+5.37%+24.57%+97.69% 511B
+0.12%+5.04%+38.75%+64.01% 377B
+3.25%+4.45%+71.80%+44.44% 366B
+0.14%+3.23%+21.10%+49.85% 291B
-0.03%+2.51%+1.08%+24.83% 262B
+3.29%+6.32%+44.71%+57.43% 237B
+2.25%+5.81%+27.13%+101.17% 194B
Average -0.28%+5.04%+27.97%+59.92% 400.79B
Weighted average by Cap. -0.18%+6.91%+40.94%+81.06%

Financials

2025 2026
Net sales 1.12B 11.87M 10.57M 9.79M 8.87M 16.68M 16.96M 117M 46.16M 588M 44.53M 43.6M 1.88B 1.06B 11.17M 9.94M 9.21M 8.35M 15.69M 15.95M 111M 43.43M 554M 41.9M 41.03M 1.77B
Net income 195M 2.06M 1.83M 1.7M 1.54M 2.89M 2.94M 20.38M 8.01M 102M 7.72M 7.56M 326M 150M 1.58M 1.41M 1.31M 1.18M 2.23M 2.26M 15.68M 6.16M 78.55M 5.94M 5.82M 251M
Net Debt -1.13B -11.9M -10.59M -9.81M -8.89M -16.71M -16.99M -118M -46.26M -590M -44.62M -43.69M -1.88B -1.35B -14.29M -12.72M -11.79M -10.68M -20.08M -20.41M -141M -55.57M -708M -53.6M -52.49M -2.26B
Projected Income Statement - Annual - Alpa Laboratories Limited
Logo Alpa Laboratories Limited
Alpa Laboratories Limited is an India-based global pharmaceutical company engaged in manufacturing and selling finished pharmaceutical dosage forms. Its product range includes a variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.
Employees
457
Date Price Change Volume
21/10/26 ₹51.22 -1.97% 7,699
19/10/26 ₹52.25 -2.26% 5,277
16/10/26 ₹53.46 -4.47% 32,050
15/10/26 ₹55.96 -2.49% 9,093
14/10/26 ₹57.39 -0.83% 3,237
  1. Stock Market
  2. Stocks
  3. ALPA Stock